UK To Reveal How Sponsors Are Performing On Trial Transparency Expectations
The UK is tightening its approach to enforcing best practices in clinical trial transparency.
You may also be interested in...
The UK regulatory agency, the MHRA, is planning to establish a “world-class sovereign regulatory environment” for clinical trials to support the development of new innovative medicines. In the first of two articles, we look at the MHRA’s proposals to slim down trial approval processes, lighten the safety reporting burden, and introduce greater transparency of trial registration and results.
The head of the UK’s medicines regulator says plans will soon be released for ensuring the country remains a preferred location for conducting clinical trials.
The UK Health Research Authority (HRA) has partnered with an international clinical trials registry to make it easier for sponsors and researchers to comply with the mandatory requirement of registering their studies in an established public database within a specific time frame.